Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults
Clinical trial NCT05266456 · COMPLETED
Trial details
- NCT number
- NCT05266456
- Sponsor
- Vaxcyte, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2023-01-10
- Enrollment
- 835
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.